|
UNC50 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.233600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.199600E-03 |
| Normal-vs-Stage2 |
1.831020E-01 |
| Normal-vs-Stage3 |
3.124000E-01 |
| Normal-vs-Stage4 |
8.595400E-01 |
| Stage1-vs-Stage2 |
5.182000E-01 |
| Stage1-vs-Stage3 |
3.110800E-01 |
| Stage1-vs-Stage4 |
1.487200E-01 |
| Stage2-vs-Stage3 |
8.190000E-01 |
| Stage2-vs-Stage4 |
3.104000E-01 |
| Stage3-vs-Stage4 |
4.333000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.077200E-03 |
| Normal-vs-AfricanAmerican |
2.164400E-01 |
| Normal-vs-Asian |
9.170200E-01 |
| Caucasian-vs-AfricanAmerican |
3.125400E-01 |
| Caucasian-vs-Asian |
4.433000E-01 |
| AfricanAmerican-vs-Asian |
7.199800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.343350E-03 |
| Normal-vs-Female |
9.139400E-01 |
| Male-vs-Female |
1.283430E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.334000E-02 |
| Normal-vs-Extreme_Weight |
2.839100E-03 |
| Normal-vs-Obese |
7.581900E-02 |
| Normal-vs-Extreme_Obese |
7.258300E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.942600E-01 |
| Normal_Weight-vs-Obese |
7.994400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.692000E-01 |
| Extreme_Weight-vs-Obese |
2.997400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.156000E-01 |
| Obese-vs-Extreme_Obese |
2.190600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.238200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.752030E-01 |
| Normal-vs-Age(61-80Yrs) |
1.058270E-03 |
| Normal-vs-Age(81-100Yrs) |
2.837600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.532370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.010390E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.500300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.543700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.442400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.262120E-02 |
| Normal-VS-Type2 PRCC |
4.279700E-02 |
| Normal-VS-KIRP CIMP |
7.256000E-01 |
| Normal-VS-Unclassified PRCC |
1.432040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.563600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.375580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.312400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.794640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.906600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.323000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.696800E-03 |
| Normal-vs-N1 |
7.088600E-01 |
| Normal-vs-N2 |
9.537000E-01 |
| N0-vs-N1 |
5.023700E-02 |
| N0-vs-N2 |
2.298600E-01 |
| N1-vs-N2 |
8.985400E-01 |
|
|
